Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction.
Marx N, Rydén L, Federici M, Marx-Schütt K, Verket M, Müller-Wieland D, Gerstein HC, Chan J, Cosentino F, Holman RR, Mellbin L, Ray KK, Standl E, Verma S, Wood D, Tuomilehto J, De Caterina R.
Marx N, et al. Among authors: holman rr.
Eur Heart J. 2024 Oct 10:ehae533. doi: 10.1093/eurheartj/ehae533. Online ahead of print.
Eur Heart J. 2024.
PMID: 39387537